Incontinentia pigmenti (IP), or Bloch-Sulzberger syndrome, is a rare X-linked dominant genodermatosis primarily affecting females. Although IP affects many organ systems, the hallmark feature of this disease is its characteristic cutaneous eruption along the lines of Blaschko that evolves through four distinct stages: inflammatory/vesiculobullous, verrucous, hyperpigmented and hypopigmented/ atrophic. We describe a case of IP in its vesicular stage that completely resolved with topical Protopic (tacrolimus) 0.1% ointment. The treatment successfully halted the progression of disease through its subsequent disfiguring stages.

Download full-text PDF

Source

Publication Analysis

Top Keywords

incontinentia pigmenti
8
pigmenti treatment
4
treatment topical
4
topical tacrolimus
4
tacrolimus incontinentia
4
pigmenti bloch-sulzberger
4
bloch-sulzberger syndrome
4
syndrome rare
4
rare x-linked
4
x-linked dominant
4

Similar Publications

Article Synopsis
  • Incontinentia pigmenti (IP) is a rare X-linked dominant disorder linked to the IKBKG gene, and this study highlights the need for more research on its epidemiology in Denmark.
  • A nationwide study identified 75 patients with IP, predominantly females, and estimated the birth prevalence at 2.37 per 100,000 live births, which is significantly higher than previous estimates.
  • The study found that many patients exhibited typical skin lesions and other symptoms affecting teeth, the nervous system, hair, eyes, and nails, indicating a multisystem impact of the disorder.
View Article and Find Full Text PDF

Finding NEMO in the thymus.

J Exp Med

November 2024

Infection Immunity and Inflammation Research and Teaching Department, University College London Institute of Child Health, London, UK.

Rosain et al. (https://doi.org/10.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!